Timothy Jinks

Wellcome Trust Ltd. Direct Investments (WTDI) is a private equity and venture capital division of the Wellcome Trust Ltd. The firm was founded in 1936 by Sir Henry Wellcome. It’s headquartered in London, UK.

Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark.

Diamond Light Source Ltd. is the UK's national synchrotron science facility, located at the Harwell Science and Innovation Campus in Oxfordshire. It works like a giant microscope, harnessing the power of electrons to produce bright light that scientists can use to study anything from fossils to jet engines to viruses and vaccines. The company is headquartered in Didcot, the United Kingdom.

WRF Capital (WRF Capital) is a venture capital firm founded in 1994 by Ronald Howell. The firm is headquartered in Seattle, Washington.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.

Canbex Therapeutics Ltd. engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain. Its lead drug candidate, VSN 16, has been established as a potent, stable and orally-available agonist of GPR-55 with a clear anti-spasticity effect in a validated preclinical model. The company was founded by David Baker, Gavin Giovannoni, Cristina Visintin, Gareth Pryce and David Lawrence Selwood in 2005 and is headquartered in London, the United Kingdom.

Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France.

VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.

Archangel Investors Ltd. is a Private Equity firm, a subsidiary of Riverside Global Partners LLC founded in 1988 by Michael David Rutterford and Barry Edward Sealey. The firm is headquartered in Boston.

Part of The Wellcome Trust Ltd., Wellcome Trust Investments 1 Unlimited is a charitable foundation based in London, UK. The British company aims to improve health and save lives by utilizing science's potential. The company provides grant funding opportunities and conduct research on mental health, infectious disease, climate and health, and discovery research. Additionally, they have a free museum called Wellcome Collection that explores health and human experience. The company also advocates for improving health for everyone through their monthly newsletter and other events.

The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.

The Wellcome Trust Ltd. (Investment Management) (Wellcome-IM) is the investment management division of The Wellcome Trust Ltd., a politically and financially independent global charitable foundation headquartered in London, UK. The Wellcome Trust was founded in 1936, in accordance with Henry Wellcome’s will, to improve health by supporting scientific research and the study of medicine. Funding for this mission came from the profits of the pharmaceutical business he had built up over 50 years. Wellcome-IM manages The Wellcome Trust.

Premier Marinas Holdings Ltd engages in the ownership and management of marians and provides its related facilities. The company is headquartered in Southampton, the United Kingdom.

Part of The Wellcome Trust Ltd., Wellcome Trust Finance Plc works with individuals and organizations to solve health challenges using science. The company is based in London, UK. Wellcome funds research, leads policy and advocacy campaigns, and builds partnerships to improve health for everyone. The British company supports discovery research into life, health, and wellbeing, and are taking on three worldwide health challenges: mental health, climate and health, and infectious diseases. Wellcome provides guidance on applying for funding, starting a grant, research policies, and more. The company also offers advice on ending a grant and managing research outputs.

Part of The Wellcome Trust Ltd., Wellcome Trust Investments 2 Unlimited is a charitable foundation that exists to improve health for everyone by supporting discovery research into life, health, and wellbeing. The company is based in London, UK and is taking on three worldwide health challenges: mental health, climate and health, and infectious diseases. The British company's investments portfolio and investments team are also highlighted in the company's description. Founded in 2008, the company's vision and strategy focus on preventing climate change from getting worse and protecting the communities most at risk.

Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million.

Part of The Wellcome Trust Ltd., Wellcome Trust Residential 1 Ltd. is a real estate investment trust. The company is based in London, UK. Founded in 2007.

Part of The Wellcome Trust Ltd., Wellcome Trust Residential 2 Ltd. engages in holding property investment. The company is based in London, UK.

Part of The Wellcome Trust Ltd., Gower Place Investments Ltd. is a British company that engages in investment activities. The company is based in London, UK and was founded in 2013.

Part of The Wellcome Trust Ltd., North London Ventures Ltd. is a company that provides investment services. The company is based in London, UK. Founded in 2012.

Part of The Wellcome Trust Ltd., Farmcare Trading Ltd. is a British company that provides farming services. The company is based in London, UK. Founded in 2014.

Part of The Wellcome Trust Ltd., W.T. Construction Ltd. is a British company that develops building projects. The company is based in London, UK. Founded in 2000.

Part of Prudential Plc, Prudential Portfolio Managers Ltd. is a British company that provides investment management services to clients. The company is based in London, UK.